Inflammatory skin diseases and the risk of chronic kidney disease: population‐based case–control and cohort analyses

Summary Background Emerging evidence suggests an association between common inflammatory skin diseases and chronic kidney disease (CKD). Objectives To explore the association between CKD stages 3–5 (CKD3–5) and atopic eczema, psoriasis, rosacea and hidradenitis suppurativa. Methods We undertook two...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of dermatology (1951) 2021-10, Vol.185 (4), p.772-780
Hauptverfasser: Schonmann, Y., Mansfield, K.E., Mulick, A., Roberts, A., Smeeth, L., Langan, S.M., Nitsch, D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Summary Background Emerging evidence suggests an association between common inflammatory skin diseases and chronic kidney disease (CKD). Objectives To explore the association between CKD stages 3–5 (CKD3–5) and atopic eczema, psoriasis, rosacea and hidradenitis suppurativa. Methods We undertook two complementary analyses; a prevalent case–control study and a cohort study using routinely collected primary care data [UK Clinical Practice Research Datalink (CPRD)]. We matched individuals with CKD3–5 in CPRD in March 2018 with up to five individuals without CKD for general practitioner practice, age and sex. We compared the prevalence of CKD3–5 among individuals with and without each inflammatory skin disease. We included individuals in CPRD with diabetes mellitus (2004–2018) in a cohort analysis to compare the incidence of CKD3–5 among people with and without atopic eczema and psoriasis. Results Our study included 56 602 cases with CKD3–5 and 268 305 controls. Cases were more likely than controls to have a history of atopic eczema [odds ratio (OR) 1·14, 99% confidence interval (CI) 1·11–1·17], psoriasis (OR 1·13, 99% CI 1·08–1·19) or hidradenitis suppurativa (OR 1·49, 99% CI 1·19–1·85), but were slightly less likely to have been diagnosed with rosacea (OR 0·92, 99% CI 0·87–0·97), after adjusting for age, sex, practice (matching factors), index of multiple deprivation, diabetes, smoking, harmful alcohol use and obesity. Results remained similar after adjusting for hypertension and cardiovascular disease. In the cohort with diabetes (N = 335 827), there was no evidence that CKD3–5 incidence was associated with atopic eczema or psoriasis. Conclusions Atopic eczema, psoriasis and hidradenitis suppurativa are weakly associated with CKD3–5. Future research is needed to elucidate potential mechanisms and the clinical significance of our findings. What is already known about this topic? Emerging evidence supports an association between more common inflammatory skin diseases and chronic kidney disease (CKD), but the size and nature of this association remain unclear. What does this study add? People with CKD were more likely to have atopic eczema (14%), psoriasis (13%) and hidradenitis suppurativa (49%), compared with those without CKD. The link between inflammatory skin diseases and CKD did not appear to be mediated through cardiovascular comorbidity, hypertension or nephrotoxic drugs. A stronger association with CKD among those with severe atopic eczema and psoriasi
ISSN:0007-0963
1365-2133
1365-2133
DOI:10.1111/bjd.20067